Objective: To prepare indapamide capsules and evaluate its dissolution.
目的：研制吲达帕胺胶囊并对其溶出度进行考察。
Conclusions Lauroyl indapamide is a weak acid with lipophilic property.
结论月桂酰吲达帕胺为弱酸性亲脂性药物。
Objective To investigate the liability of indapamide-induced kaliopenia.
目的探讨吲达帕胺致低钾血症的易患性。
Conclusion: The dissolution of indapamide capsules are coincidence with requirement.
结论：所研制的吲达帕胺胶囊溶出度符合要求。
Objective to establish HPLC method to determine the content of indapamide sustained release tablets.
目的建立高效液相色谱法测定吲达帕胺缓释片含量。
Conclusion The efficacy and safety of potassium alginate for hypertension was similar to indapamide.
结论海藻酸钾散剂与寿比山具有相似的降压疗效，是一种安全、有效的降压药。
The link between blood free calcium or PRA and the depressive effect of indapamide was not ascertained.
未证实血游离钙或肾素活性和降压幅度之间存在联系。
Objectives: To improve the determining method of content uniformity in dissolution of indapamide tablet.
目的：对吲达帕胺片含量均匀度测定中样品的溶解方法进行改进。
Objective to observe the effect of serum kalium on depressurization of captopril combine with Indapamide and using them alone.
目的观察卡托普利联合吲达帕胺与单用吲达帕胺、卡托普利降压疗效及对血钾的影响。
OBJECTIVE To investigate the efficacy and safety of Losartan in combination with indapamide in elderly with essential hypertension.
目的探讨联合应用氯沙坦和吲哒帕胺对老年轻、中、度高血压病的疗效、顺应性及对靶器官损害的影响。
In the Progress trial, perindopril and indapamide was shown to be useful also for secondary prevention of stroke. This is another risk group.
在Progress试验中，培多普利和吲哒帕胺显示对中风的2级预防有效，这是另一个危险人群。
Objective: To set up a new method for the separation of 7 diuretics: triamterene, amiloride, furosemide, bumetanide, chlorothiazide, indapamide and bendroflumethiazide.
目的：建立分离测定氨苯蝶啶、阿米洛利、呋塞米、布美他尼、氟噻嗪、吲达帕胺、苄氟噻嗪等7种利尿药的新方法。
Conclusions The results provide evidence that antihypertensive treatment with indapamide (sustained release), with or without perindopril, in persons 80 years of age or older is beneficial.
结论：研究结果为吲达帕胺(缓释片)单用或联合培哚普利用于80岁以上老年人降压治疗的临床获益提供了证据。
Conclusions The results provide evidence that antihypertensive treatment with indapamide (sustained release), with or without perindopril, in persons 80 years of age or older is beneficial.
结论：研究结果为吲达帕胺(缓释片)单用或联合培哚普利用于80岁以上老年人降压治疗的临床获益提供了证据。
应用推荐